| Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity M Hervé, K Xu, YS Ng, H Wardemann, E Albesiano, BT Messmer, ... The Journal of clinical investigation 115 (6), 1636-1643, 2005 | 437 | 2005 |
| Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody R Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ... Science 352 (6287), 828-833, 2016 | 361 | 2016 |
| Architecture of Eph receptor clusters JP Himanen, L Yermekbayeva, PW Janes, JR Walker, K Xu, L Atapattu, ... Proceedings of the National Academy of Sciences 107 (24), 10860-10865, 2010 | 321 | 2010 |
| Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ... Nature medicine 24 (6), 857-867, 2018 | 301 | 2018 |
| Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2 P Qu, JP Evans, JN Faraone, YM Zheng, C Carlin, M Anghelina, ... Cell host & microbe 31 (1), 9-17. e3, 2023 | 232 | 2023 |
| Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ... Nature 595 (7866), 278-282, 2021 | 211 | 2021 |
| Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3 K Xu, KR Rajashankar, YP Chan, JP Himanen, CC Broder, DB Nikolov Proceedings of the National Academy of Sciences 105 (29), 9953-9958, 2008 | 209 | 2008 |
| Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism K Xu, Z Wu, N Renier, A Antipenko, D Tzvetkova-Robev, Y Xu, ... Science 344 (6189), 1275-1279, 2014 | 199 | 2014 |
| Quantification of the impact of the HIV-1-glycan shield on antibody elicitation T Zhou, NA Doria-Rose, C Cheng, GBE Stewart-Jones, GY Chuang, ... Cell reports 19 (4), 719-732, 2017 | 187 | 2017 |
| A treatment for and vaccine against the deadly Hendra and Nipah viruses CC Broder, K Xu, DB Nikolov, Z Zhu, DS Dimitrov, D Middleton, J Pallister, ... Antiviral research 100 (1), 8-13, 2013 | 171 | 2013 |
| Observation of Dicke cooperativity in magnetic interactions X Li, M Bamba, N Yuan, Q Zhang, Y Zhao, M Xiang, K Xu, Z Jin, W Ren, ... Science 361 (6404), 794-797, 2018 | 143 | 2018 |
| Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation DB Nikolov, K Xu, JP Himanen Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (10), 2160-2165, 2013 | 138 | 2013 |
| Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2 JP Evans, C Zeng, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... Cell host & microbe 30 (8), 1093-1102. e3, 2022 | 133 | 2022 |
| Enhanced evasion of neutralizing antibody response by Omicron XBB. 1.5, CH. 1.1, and CA. 3.1 variants P Qu, JN Faraone, JP Evans, YM Zheng, C Carlin, M Anghelina, ... Cell reports 42 (5), 2023 | 120 | 2023 |
| Antibody lineages with vaccine-induced antigen-binding hotspots develop broad HIV neutralization R Kong, H Duan, Z Sheng, K Xu, P Acharya, X Chen, C Cheng, ... Cell 178 (3), 567-584. e19, 2019 | 120 | 2019 |
| Vaccine induction of heterologous tier 2 HIV-1 neutralizing antibodies in animal models KO Saunders, LK Verkoczy, C Jiang, J Zhang, R Parks, H Chen, ... Cell reports 21 (13), 3681-3690, 2017 | 107 | 2017 |
| Structure-based design of a soluble prefusion-closed HIV-1 Env trimer with reduced CD4 affinity and improved immunogenicity GY Chuang, H Geng, M Pancera, K Xu, C Cheng, P Acharya, ... Journal of virology 91 (10), 10.1128/jvi. 02268-16, 2017 | 102 | 2017 |
| Neutralization and stability of SARS-CoV-2 Omicron variant C Zeng, JP Evans, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... biorxiv, 2021 | 95 | 2021 |
| Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly K Xu, YP Chan, B Bradel-Tretheway, Z Akyol-Ataman, Y Zhu, S Dutta, ... PLoS pathogens 11 (12), e1005322, 2015 | 93 | 2015 |
| Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4 GBE Stewart-Jones, GY Chuang, K Xu, T Zhou, P Acharya, Y Tsybovsky, ... Proceedings of the National Academy of Sciences 115 (48), 12265-12270, 2018 | 92 | 2018 |
Christopher C BroderUniformed Services University, Department of DefenseVerified email at usuhs.edu